Dienophilicity of imidazole in inverse electron demand Diels-Alder reactions; intermolecular reactions with 1,2,4-triazines

Tetrahedron Letters

Volumn 38, Issue 43, 1997, Pages 7495-7498

  Wan, Zhaokui ^a   Snyder, John K ^a  

^a Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIDAZO[4,5 C]PYRIDINE DERIVATIVE; PYRIDO[3,2 D]PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; IN VITRO STUDY; REACTION ANALYSIS;

EID: 0030808978     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(97)01799-1     Document Type: Article

References (44)

1. Reviews of inverse electron demand Diels-Alder reactions: (a) Boger, D.L. Tetrahedron 1983, 39, 2869 - 2939.
2. (b) Boger, D.L. Chem. Rev. 1986, 86, 781 - 793.
3. (c) Boger, D.L.; Weinreb, S.N. Hetero Diels-Alder Methodology in Organic Synthesis; Organic Chemistry Monograph Series, Vol. 47; Wasserman, H. H., Ed; Academic: New York, 1987; Chapters 9 and 10.
4. Benson, S.C.; Lee, L.; Snyder, J.K. Tetrahedron Lett. 1996, 37, 5061 - 5064, and literature cited therein (ref. 1).
5. For some recent lead references on 3-deazapurines and their biological activity: (a) Impagnatiello, A.; Franceschini, N.; Oratore, A.; Bozzi, A. Biochimie 1996, 78, 267 - 272.
6. (b) Minakawa, N.; Sasbuchi, Y.; Kiyosue, A.; Kojima, N.; Matsuda, A. Chem. Pharm. Bull. 1996, 44, 288 - 295.
7. (c) Carceller, E.; Merlos, M.; Giral, M.; Balsa, D.; Garcia-Rafanell, J.; Forn, J. J. Med. Chem. 1996, 39, 487 - 493.
8. (d) Shuto, S.; Obara, T.; Saito, Y.; Andrei, G.; Snoeck, R.; De Clerq, E.; Matsuda, A. J. Med. Chem. 1996, 39, 2392 - 2399.
9. (e) Endresen, P.C.; Loennechen, T.; Kildalsen, H.; Aarbakke, J. J. Pharm. Exp. Ther. 1996, 278, 1318 - 1324.
10. (f) Mederski, W.W.K.R.; Dorsch, D.; Osswald, M.; Beier, N.; Lues, I.; Minck, K.-O.; Schelling, P.; Ladstetter, B. J. Bioorg. Med. Chem. Lett. 1995, 5, 2665 - 2670.
11. Isolation and bioactivity of the grossularines: (a) Helbecque, N.; Moquin, C.; Bernier, J.-L.; Morel, E.; Guyot, M.; Henichart, J.-P. Cancer Biochem. Biophys. 1987, 9, 271 - 279.
12. (b) Moquin-Pattey, C.; Guyot, M. Tetrahedron 1989, 45, 3445 - 3450.
13. (c) Abas, S.A.; Hossain, M.B.; van der Helm, D.; Schmitz, F.J.; Laney, M.; Cabuslay, R.; Shatzman, R.C. J. Org. Chem. 1996, 61, 2709 - 2712.
14. Syntheses and synthetic studies: (d) Achab, S.; Guyot, M.; Potier, P. Tetrahedron Lett. 1993, 34, 2127 - 2130.
15. (e) Chosh T.; Yamada, S.; Sugino, E.; Kawada, T.; Hibino, S. J. Org. Chem. 1995, 60, 5899 - 5904, and references therein.
16. (a) Seitz, G.; Kaempchen, T. Arch. Pharm. (Weinheim) 1978, 311, 728 - 735.
17. (b) Seitz, G.; Hoferichter, R.; Mohr, R. Arch. Pharm. (Weinheim) 1989, 322, 415 - 417.
18. (a) Xu, Y.-Z.; Yakushijin, K.; Horne, D.A. Tetrahedron Lett. 1993, 34, 6981 - 6984.
19. Horne has also reported a [4+6]-condensation of 4-alkyl-2-aminoimidazoles: (b) Xu, Y.-Z.; Yakushijin, K.; Horne, D.A. J. Org. Chem. 1997, 60, 9569 - 9571.
20. Boger D.L., Panek J.S., Yasuda M. Org. Synth. 66:1987;142-150.
21. (a) Martin, J.C.; Muchowski, J.M. J. Org. Chem. 1984, 49, 1040 - 1043.
22. (b) Boger, D.L.; Panek, J.S. J. Am. Chem. Soc. 1985, 107, 5745 - 5754.
23. (c) Rocha Gonsalves, A.M. d'A.; Pinho e Melo, T.M.V. D.; Gilchrist, T.L. Tetrahedron 1993, 49, 5277 - 5290.
24. (a) Zemlicka, J.; Holy, A. Coll. Czech. Chem. Commun. 1967, 32, 3159 - 3168.
25. (b) Taylor, E.C.; LaMuttina, J.L. J. Org. Chem. 1977, 42, 1523 - 1527.
26. (c) Taylor, E.C.; Dumas, D.J. J. Org. Chem. 1980, 45, 2485 - 2489.
27. Similar rearrangements are known in the cycloaddition chemistry of indoles: (a) Acheson, R.M.; Bridson, J.N.; Cecil, T.R.; Hands, A.R. J. Chem. Soc., Perk. Trans. I 1972, 1569 - 1576.
28. (b) Seitz, G.; Kaempchen, T. Arch. Pharm. (Weinheim) 1976, 309, 679 - 681.
29. (c) Benson, S.C.; Palabrica, C.A.; Snyder, J.K. J. Org. Chem. 1987, 52, 4610 - 4614.
30. (d) Benson, S.C.; Gross, J.L.; Snyder, J.K. 1990, 55, 3257 - 3269.
31. For a recent review of pyridopyrimidines: Warner, J.C. In The Chemistry of Heterocyclic Compounds; Taylor, E.C., Ed.; John Wiley & Sons: New York, 1992; Vol. 24, Part 4: Fused Pyrimidines; Miscellaneous Fused Pyrimidines, Chapter 1.
32. Martin J.C. J. Org. Chem. 47:1982;3761-3763.
33. (a) Schmidt, P.; Druey, J. Helv. Chim. Acta 1955, 38, 1560 - 1564.
34. (b) Elix, J.A.; Wilson, W.S.; Warrener, R.N.; Calder, I.C. Aust. J. Chem. 1972, 25, 865 - 874.
35. For the preparation of 2d, see ref. 10d; 2d had appeared in the literature prior to this, but without accompanying details for its preparation or characterization: (a) Neunhoeffer, H.; Fruhauf, H.W. Tetrahedron Lett. 1970, 3355 - 3356.
36. (b) Burg, B.; Dittmar, W.; Reim, H.; Steigel, A.; Sauer, J. Tetrahedron Lett. 1975, 2897 - 2890.
37. (c) Reim, H.; Steigel, A.; Sauer, J. Tetrahedron Lett. 1975, 2901 - 2904. For reviews of 1,2,4-triazine preparation:
38. (d) Neunhoeffer, H. Chemistry of 1,2,3-Triazines and 1,2,4-Triazines, Tetrazines, and Pentazines; The Chemistry of Heterocyclic Compounds Monograph Series, Vol. 33; Wiley-Interscience: New York, 1978; pp 189 - 574.
39. (e) Neunhoeffer, H. In Comprehensive Heterocyclic Chemistry; Boulton, A.J., McKillop, A., Eds.; Pergamon: Oxford, 1984; Vol. 3, pp 385 - 456.
40. A rearrangement mechanism involving tautomerization of 3,4-dihydropyridine intermediate A (Scheme 2) to the more stable 1,4-dihydropyridine is also conceivable. (a) Bodor, N.; Pearlman, R. J. Am. Chem. Soc. 1978, 100, 4946 - 4953.
41. (b) Bohm, S.; Kuthan, J. Coll. Czech. Chem. Commun. 1981, 46, 2068 - 2075.
42. (c) Bohm, S.; Kuthan, J. Coll. Czech. Chem. Commun. 1982, 47, 2735 - 2745. Such a tautomerization has been invoked by Seitz for the analogous rearrangement of the indole cycloadduct, ref. 10b.
43. For lead references to the 8-deazapteridines and their biological applications: (a) Rewcastle, G.W.; Palmer, B.D.; Thompson, A.M.; Bridges, A.J.; Cody, D.R.; Zhou, H.; Fry, D.W.; McMichael, A.; Denny, W.A. J. Med. Chem. 1996, 39, 1823 - 1835.
44. (b) Gangjee, A.; Zhu, Y.; Queener, S.F.; Francorn, P.; Broom, A.D. J. Med. Chem. 1996, 39, 1836 - 1845.